SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-21-009777
Filing Date
2021-02-16
Accepted
2021-02-16 19:01:34
Documents
2
Period of Report
2021-02-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 5443
2 POWER OF ATTORNEY ea135251ex24_virpaxpharma.htm EX-24 7024
  Complete submission text file 0001213900-21-009777.txt   13911
Mailing Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380
Business Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380 484-875-3195
Virpax Pharmaceuticals, Inc. (Issuer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VIRPAX PHARMACEUTICALS, INC. 1554 PAOLI PIKE #279 WEST CHESTER PA 19380
Business Address
Mack Anthony P. (Reporting) CIK: 0001818483 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40064 | Film No.: 21641815